Stocks Health care APLM
NASDAQ · Health careApollomics Inc. (APLM)
Apollomics Inc. reported revenue of $0 in fiscal 2024. It posted a net loss of $53.9M. In fiscal 2024 capital spending exceeded operating cash flow by $28.8M. At December 31, 2024 it held $9.8M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 24, 2026.
What Apollomics Inc. does
Apollomics Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker APLM.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | $0 | -$53.9M | -$52.80 | -$28.8M |
| 2023 | $0 | -$172.6M | -$231.99 | -$43.2M |
| 2022 | $0 | -$240.8M | -$844.95 | -$43.2M |
| 2022 | $0 | -$94.8M | -$337.38 | -$43.4M |
| 2020 | $0 | -$74.8M | -$308.04 | -$35.8M |
Latest SEC filings
What Apollomics Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 8, 2026
- August 17, 2026Activist stake changed SCHEDULE 13D/A
- August 14, 2026Activist stake changed SCHEDULE 13D/A
- August 12, 2026
- July 21, 2026
- July 14, 2026
- June 24, 2026
- May 15, 2026Form F-3/A filing F-3/A
- April 27, 2026
- April 24, 2026Annual report (foreign issuer) 20-F · period to December 31, 2025
Questions about APLM
What does Apollomics Inc. do?
Apollomics Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker APLM.
Is Apollomics Inc. profitable?
No. In fiscal 2024 it reported a net loss of $53.9M.
How much revenue does Apollomics Inc. make?
In fiscal 2024 Apollomics Inc. reported revenue of $0.
When did Apollomics Inc. last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 24, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the insider trade (amended) from September 24, 2026.
Similar companies
Follow APLM
Get an email when Apollomics Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow APLM: get an email when it filesWhere the numbers come from
Financial figures are the values Apollomics Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.